Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To investigate the local bronchodilatory effects of 3 different doses of AZD2115 compared with placebo, with respect to peak and trough forced expiratory volume in the first second (FEV1), in patients with chronic obstructive pulmonary disease (COPD).
Critère d'inclusion
- AZD2115 is being developed to treat chronic obstructive pulmonary disease (COPD)